The Senate isn’t wasting any time with Trump’s FDA pick
Two months ago, we learned that President Trump was probably going to nominate Dr. Stephen Hahn to run the FDA. Last week, Trump actually did so. The Senate, by contrast, is moving quite a bit faster.
Yesterday, Sen. Lamar Alexander endorsed Hahn after “an excellent meeting,” and he scheduled a confirmation hearing before the Senate health committee for Nov. 20. If the MD Anderson oncologist gets through that, the full Senate could vote on his nomination as early as December, which could put Hahn in office before the year’s out.
Or not. Back in 2017, Dr. Scott Gottlieb made his way through the confirmation process in less than two months, but that was before the national vaping crisis and widespread concern about dubiously marketed CBD products. Hahn’s trip toward confirmation could be rockier.
Yesterday, Sen. Lamar Alexander endorsed Hahn after “an excellent meeting,” and he scheduled a confirmation hearing before the Senate health committee for Nov. 20. If the MD Anderson oncologist gets through that, the full Senate could vote on his nomination as early as December, which could put Hahn in office before the year’s out.
Or not. Back in 2017, Dr. Scott Gottlieb made his way through the confirmation process in less than two months, but that was before the national vaping crisis and widespread concern about dubiously marketed CBD products. Hahn’s trip toward confirmation could be rockier.
No hay comentarios:
Publicar un comentario